EGF and hepatocellular carcinoma: Daphnetin could inhibit EGF-induced tyrosine phosphorylation of EGF receptor in the presence of ATP in vitro, whereas it could not repress EGF-induced tyrosine phosphorylation of EGF receptor in human hepatocellular carcinoma HepG2 cells (46).